Q4 2020 Holdings
Filed 2021-02-12 | 62 holdings | $17.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $11.0M | 155,000 | 61.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.7M | 10,000 | 9.4% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $1.5M | 70,000 | 8.2% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $1.3M | 75,000 | 7.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $815.0K | 10,000 | 4.6% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $686.0K | 100,000 | 3.9% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $663.0K | 20,000 | 3.7% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $29.6K | 225,000 | 0.2% |
| Spdr S&P 500 ETF Trust Trust(SPY)Put | TR UNIT | 78462F103 | $15.0K | 40,000 | 0.1% |
| Curis Inc(CRISEUR) | COM | 231269200 | $11.9K | 1,450,000 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $8.5K | 260,000 | 0.0% |
| Vincera Pharma Inc | COM | 92731L106 | $8.4K | 403,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.8K | 105,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $5.8K | 45,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $4.6K | 220,000 | 0.0% |
| Cerevel Therapeutics Holdings I(CERE1EUR) | COM | 15678U128 | $4.5K | 270,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $4.3K | 200,000 | 0.0% |
| Retrophin Inc | NOTE 2.500 9/15/2025 | 761299AB2 | $4.0K | $4,000,000 | 0.0% |
| ARK ETF TR(ARKG)Put | GENOMIC REV ETF | 00214Q302 | $3.7K | 40,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.5K | 75,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX)Call | COM | 87164F105 | $3.3K | 150,500 | 0.0% |
| Horizon Therapeutics PLC | SHS | G46188101 | $3.3K | 45,000 | 0.0% |
| Arya Sciences Acquisition Co | COM CL A | G3166W106 | $3.3K | 300,000 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $3.2K | 300,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $3.1K | 65,000 | 0.0% |
| Health Sciences Acquisitions Corp 2 | ORD SHS | G4411D109 | $2.6K | 200,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $2.4K | 150,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.4K | 10,000 | 0.0% |
| Morphic Holding Inc | COM | 61775R105 | $2.3K | 67,500 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $2.2K | 625,000 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $2.2K | 200,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.2K | 10,000 | 0.0% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $2.2K | 50,000 | 0.0% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $2.0K | 25,000 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $2.0K | 904,600 | 0.0% |
| Solid Biosciences IncCall | COM | 83422E105 | $1.9K | 250,000 | 0.0% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $1.5K | 100,000 | 0.0% |
| Longview Acquisition Corp | COM CL A | 543195101 | $1.5K | 75,000 | 0.0% |
| Pulmonx Corporation(LUNG) | COM | 745848101 | $1.4K | 20,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.3K | 50,000 | 0.0% |
| Pandion Therapeutics Inc(PAND) | COM | 698340106 | $1.2K | 80,000 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $1.1K | 100,000 | 0.0% |
| Vesper Healthcare Acquisition Corp | COM CL A | 92538T104 | $1.1K | 100,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $918 | 117,545 | 0.0% |
| Beyondspring Inc(BYSI) | SHS | G10830100 | $915 | 75,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $909 | 19,600 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $881 | 40,000 | 0.0% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $873 | 10,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $855 | 45,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $797 | 30,000 | 0.0% |